Researchers at the Tony Blair Institute have called for the eligibility criteria for the drugs to 'drastically lowered', ...

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Cheryl Burke slammed the speculation that she'd undergone plastic surgery and used Ozempic, saying she's 'not sick' and ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Kathy Bates lost 100 pounds after a diabetes diagnosis. Here are the key lifestyle changes that helped her transform her body and health ...

A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Fact checked by Nick Blackmer Weight loss medications like Ozempic can have various effects on patients with eating disorders ...

The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...

Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.